Q32 Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Q32 Bio Inc.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body’s first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.
/ 
Frequently asked questions
To buy Q32 Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Q32 Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Q32 Bio Inc. is QTTB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Q32 Bio Inc. has its primary listing on NASDAQ. You can trade Q32 Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Q32 Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Q32 Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Q32 Bio Inc..